Study of Blood Samples in Patients With Breast Cancer
- Conditions
- Breast Cancer
- Registration Number
- NCT00959556
- Lead Sponsor
- Centre Oscar Lambret
- Brief Summary
RATIONALE: Studying the genes expressed in samples of blood from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to chemotherapy.
PURPOSE: This clinical trial is studying blood samples in patients with breast cancer.
- Detailed Description
OBJECTIVES:
* Identify constitutional gene variants associated with a change in response.
OUTLINE: Blood samples are collected periodically for analysis of genetic factors.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 900
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Histologic complete response (Chevallier and Sataloff) or tumor response (RECIST)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Centre Oscar Lambret
🇫🇷Lille, France